How to Cure PCOS Permanently: UK Guide

How to cure PCOS permanently is one of the most common questions asked by those living with polycystic ovary syndrome. The honest answer is that a permanent cure does not currently exist, but PCOS can be managed so effectively that many people experience minimal disruption to their daily lives. This article explains what the NHS and NICE guidance say about long-term management, which lifestyle changes and medications are most evidence-based, what risks arise if PCOS is left untreated, and how to access the right support at each stage of your care.

Can PCOS be cured permanently, or is it lifelong?

PCOS cannot currently be cured permanently; it is a chronic hormonal condition whose symptoms can be managed but whose underlying imbalances do not resolve spontaneously in most cases.

Polycystic ovary syndrome (PCOS) cannot currently be cured permanently, but its symptoms can be effectively managed throughout a person's life. PCOS is a complex hormonal condition affecting roughly 1 in 10 people with ovaries in the UK, according to the NHS.^[1] Its underlying hormonal imbalances, including elevated androgens and disrupted insulin signalling, are chronic in nature and do not resolve spontaneously in most cases.

Diagnosis in the UK is based on the Rotterdam criteria, which require at least two of the following three features: irregular or absent periods, clinical or biochemical signs of elevated androgens, and polycystic-appearing ovaries on ultrasound. Importantly, a diagnosis can be made on clinical and biochemical grounds alone; ultrasound is not always required and is not recommended as a diagnostic tool in adolescents, in whom polycystic-appearing ovaries may be a normal finding.^[2]

The experience of PCOS changes over time. Some people find that symptoms such as irregular periods become less pronounced after the menopause, when ovarian hormone production naturally declines. However, the diagnostic label and associated metabolic risks, including those related to insulin resistance, may persist beyond the reproductive years.

The goal of management is therefore not cure but long-term symptom control and risk reduction. With the right combination of lifestyle measures and, where appropriate, medical treatment, many people with PCOS lead healthy, fulfilling lives with well-controlled symptoms. Early diagnosis and consistent management are key to achieving this.

What treatments does the NHS offer for managing PCOS?

The NHS offers a stepped approach starting with lifestyle modification, progressing to medications such as the combined oral contraceptive pill or metformin, with referral to gynaecology, endocrinology, or fertility services where needed.

The NHS offers a range of treatments for PCOS, tailored to each person's individual symptoms and reproductive goals. NICE CKS: Polycystic ovary syndrome and NICE CG156 (Fertility problems: assessment and treatment) together inform a stepped approach, beginning with lifestyle modification and progressing to pharmacological treatment where needed. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online consultations, with prescriber review and pharmacist support, for those exploring their options alongside NHS care.

Initial assessment by a GP typically includes a pregnancy test, blood tests (LH, FSH, testosterone, SHBG or free androgen index, prolactin, TSH, fasting glucose or HbA1c, and a fasting lipid profile), and pelvic ultrasound where clinically indicated.^[2] Other causes of androgen excess or menstrual irregularity, such as thyroid disease, hyperprolactinaemia, and congenital adrenal hyperplasia, should be excluded before confirming a PCOS diagnosis. Ultrasound is not recommended for diagnosing PCOS in adolescents.

For menstrual irregularity, the combined oral contraceptive pill is commonly prescribed to regulate cycles and reduce androgen-related symptoms such as acne and excess hair growth. For those trying to conceive, ovulation induction with letrozole or clomifene may be offered; letrozole is the preferred first-line option per NICE CG156, though it is used off-label for this indication in the UK and should be initiated and monitored within a specialist fertility service.^[3][4]

Referral pathways within the NHS include:

• GP assessment for initial diagnosis, investigations, and first-line management

• Gynaecology or endocrinology referral for complex hormonal management, fertility concerns, or suspected secondary causes

• Dietitian referral for support with weight management and insulin resistance

• Dermatology referral for persistent acne or hirsutism not responding to first-line treatment

• Urgent referral (in line with NICE NG12) if there are symptoms that may indicate endometrial cancer, such as postmenopausal bleeding, persistent intermenstrual bleeding, or heavy irregular bleeding in someone at elevated endometrial risk

Red flags warranting prompt assessment include rapid-onset virilisation, markedly elevated androgens, persistent amenorrhoea beyond three to six months without explanation, or clinical features suggesting Cushing's syndrome or thyroid disease. Access to specific treatments may vary depending on the local Integrated Care Board (ICB), so it is worth discussing all available options with a GP.

How do lifestyle changes help control PCOS symptoms long-term?

Lifestyle changes, including regular exercise and a low-GI diet, improve insulin sensitivity and hormonal balance; even a 5% reduction in body weight can meaningfully improve menstrual regularity and fertility outcomes.

Lifestyle changes are one of the most effective long-term strategies for managing PCOS symptoms, particularly for those with insulin resistance or excess weight. NICE CKS: Polycystic ovary syndrome notes that even a modest reduction in body weight of 5% can meaningfully improve hormonal balance, menstrual regularity, and fertility outcomes in people with PCOS who are overweight.^[2]

Regular physical activity plays a central role. Both aerobic exercise (such as brisk walking, cycling, or swimming) and resistance training have been shown to improve insulin sensitivity, reduce androgen levels, and support a healthy weight. NHS physical activity guidelines for adults recommend at least 150 minutes of moderate-intensity activity per week.^[6]

Dietary approaches that reduce refined carbohydrates and prioritise low-glycaemic index (GI) foods may help stabilise blood glucose and insulin levels, which are often dysregulated in PCOS. There is no single PCOS diet endorsed by NICE, but a balanced, varied diet rich in vegetables, wholegrains, lean protein, and healthy fats is broadly recommended. The British Dietetic Association provides further guidance on nutrition for people with PCOS.

Sleep quality and stress management also matter. Chronic stress and poor sleep can affect hormonal regulation and may worsen insulin resistance; managing these factors is therefore considered a useful complement to other lifestyle measures, and may support adherence and overall wellbeing. Techniques such as mindfulness, cognitive behavioural therapy (CBT), and good sleep hygiene may help.

These changes are not a cure, but sustained over time they can significantly reduce the burden of PCOS symptoms and lower the risk of long-term complications.

Which medications are commonly used to treat PCOS in the UK?

Common medications include combined oral contraceptives for cycle regulation, metformin for insulin resistance, and letrozole or clomifene for ovulation induction; none are licensed specifically for PCOS as a whole.

Several medications are used in the UK to manage specific aspects of PCOS, though none are licensed specifically for the condition as a whole. Treatment is therefore symptom-directed and guided by individual clinical need.

Hormonal contraceptives are frequently prescribed to regulate menstrual cycles and reduce androgen-driven symptoms. Combined oral contraceptive pills containing an anti-androgenic progestogen (such as drospirenone or cyproterone acetate) are often preferred for this purpose.

Co-cyprindiol (cyproterone acetate with ethinylestradiol) is licensed for severe acne and hirsutism that has not responded to other treatments; it is not recommended as a routine contraceptive. It carries a higher risk of venous thromboembolism (VTE) than most combined pills and should generally be stopped three to four months after symptoms have been adequately controlled.^[7][8] It must not be used during pregnancy. Prescribers will assess individual VTE risk before initiating it.

Metformin, a biguanide licensed for type 2 diabetes, is widely used off-label in PCOS to improve insulin sensitivity. NICE CKS: Polycystic ovary syndrome supports its use, particularly where lifestyle measures alone have been insufficient. It may also improve menstrual regularity and support ovulation. Common side effects include gastrointestinal upset; long-term use may be associated with reduced vitamin B12 absorption, so monitoring is advisable per BNF guidance.^[9][10]

Letrozole (an aromatase inhibitor) and clomifene (a selective oestrogen receptor modulator) are used to induce ovulation in those trying to conceive. Letrozole is the preferred first-line option per NICE CG156, though it is used off-label for this indication in the UK. Both should be initiated and monitored within a specialist fertility service.

Spironolactone may be considered for hirsutism or acne where other treatments have not been effective. It requires reliable contraception throughout treatment because of its anti-androgenic effects, which carry a risk of feminisation of a male foetus.^[2] Potassium levels and renal function should be monitored during treatment, and interactions with other medicines (including ACE inhibitors and potassium-sparing diuretics) should be reviewed by the prescriber.

GLP-1 receptor agonists such as semaglutide (Wegovy, available in doses up to 7.2 mg weekly in the UK) have attracted interest for their effects on weight and insulin resistance in PCOS, though their use in this context remains off-label. People planning a pregnancy should be aware that semaglutide must be stopped well before conception, as advised in the Wegovy UK SmPC; a prescriber can advise on the appropriate washout period. Any medication should be discussed with a qualified prescriber who can assess individual suitability, explain off-label status where relevant, and review risks and benefits.

What are the risks of leaving PCOS unmanaged over time?

Unmanaged PCOS increases the risk of type 2 diabetes, cardiovascular disease, endometrial hyperplasia or cancer, and mental health conditions such as anxiety and depression.

Leaving PCOS unmanaged over time carries meaningful long-term health risks that extend well beyond reproductive concerns.

Type 2 diabetes: People with PCOS, particularly those with insulin resistance, obesity, or a family history of diabetes, face an increased risk of developing type 2 diabetes. NICE CKS: Polycystic ovary syndrome recommends screening at diagnosis and then every one to three years thereafter, using HbA1c or fasting glucose.^[2][14] An oral glucose tolerance test (OGTT) may be preferred in higher-risk individuals, including those planning a pregnancy.

Cardiovascular risk: Dyslipidaemia, hypertension, and chronic low-grade inflammation are more common in people with PCOS, and these factors collectively contribute to elevated cardiovascular risk over time. Absolute event risk remains an area of ongoing study, but addressing modifiable risk factors through lifestyle and, where appropriate, medication is important for long-term heart health.

Endometrial health: Infrequent or absent periods mean the endometrium (womb lining) is not shed regularly, which over time can lead to endometrial hyperplasia and, in some cases, an increased risk of endometrial cancer. NICE CKS: Polycystic ovary syndrome recommends that people with PCOS who have fewer than three to four periods per year should receive treatment to induce a withdrawal bleed at least every three to four months.^[2] Options to protect the endometrium include the combined oral contraceptive pill, cyclical progestogen, or a levonorgestrel-releasing intrauterine system (LNG-IUS), as appropriate to individual circumstances. If you experience postmenopausal bleeding, persistent intermenstrual bleeding, or heavy irregular bleeding, seek prompt medical assessment; your GP can refer urgently if needed in line with NICE NG12.

Mental health: Anxiety, depression, and poor body image are more prevalent in people with PCOS, and these should be actively screened for and addressed as part of holistic care.^[16][17] NHS Talking Therapies (previously IAPT) offers free psychological support, including CBT, for eligible adults in England; equivalent services are available in Scotland, Wales, and Northern Ireland. Your GP can refer you or advise on self-referral options.

If you are concerned about any of these risks, speak to your GP, who can arrange appropriate monitoring and refer you to relevant specialists. Contact NHS 111 if you need urgent advice outside of GP hours.

Scientific References

1. Polycystic ovary syndrome (PCOS) – NHS.
2. Polycystic ovary syndrome – NICE Clinical Knowledge Summary.
3. Fertility problems: assessment and treatment (CG156).
4. Polycystic ovary syndrome: Adaptation report 5 (GID-NG10436).
5. First-line ovulation induction for polycystic ovary syndrome.
6. Physical activity guidelines for adults aged 19 to 64 – NHS.
7. Cyproterone acetate with ethinylestradiol (co-cyprindiol): balance of benefits and risks remains positive – MHRA.
8. Co-cyprindiol – BNF.
9. Metformin hydrochloride – BNF.
10. Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk – MHRA.
11. Wegovy EPAR product information – EMA.
12. Medicines regulator approves up to 7.2 mg dose of semaglutide/Wegovy for patients with obesity only – MHRA.
13. Semaglutide – BNF.
14. Diagnostic accuracy of oral glucose tolerance tests, fasting glucose and HbA1c for type 2 diabetes in women with PCOS.
15. Screening for endometrial hyperplasia and endometrial cancer in premenopausal women with PCOS – BMJ Open.
16. Depression and anxiety among women with polycystic ovarian syndrome in low- and middle-income countries: a systematic review and meta-analysis – Frontiers in Global Women's Health.
17. Yoga as a complementary intervention for polycystic ovary syndrome management: a systematic review – Frontiers in Reproductive Health.

Frequently Asked Questions